Related Experiment Video
Updated: Mar 30, 2026
18:30
RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
Published on: February 13, 2013
22.5K
TGF-β1 and Serpine 1 expression changes in traumatic deep vein thrombosis
1Department of Orthopedic Surgery, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi Province, China.
Genetics and Molecular Research : GMR
|November 5, 2015
Summary
Transforming growth factor β1 (TGF-β1) and Serpine 1 levels rise before deep vein thrombosis (DVT) formation in rats. Overexpression of these factors may predict and contribute to DVT development.
Area of Science:
- Vascular Biology
- Molecular Biology
- Biochemistry
Background:
- Deep vein thrombosis (DVT) is a significant clinical condition.
- Understanding the molecular mechanisms underlying DVT is crucial for developing effective treatments.
- Transforming growth factor β1 (TGF-β1) and Serpine 1 are implicated in various biological processes, including coagulation and inflammation.
Purpose of the Study:
- To investigate the expression changes of TGF-β1 and Serpine 1 in a rat model of traumatic deep vein thrombosis (DVT).
- To analyze the relationship between TGF-β1 and Serpine 1 expression and DVT formation.
- To explore the potential role of these factors in the pathogenesis and prediction of DVT.
Main Methods:
- Establishment of a traumatic DVT model in Sprague Dawley rats.
- Gene expression analysis using microarray and quantitative polymerase chain reaction (PCR).
- Bioinformatic analysis to elucidate regulatory pathways.
Main Results:
- TGF-β1 and Serpine 1 expression significantly increased at 2.5 hours post-modeling, preceding DVT onset at 25 hours.
- Significantly higher TGF-β1 and Serpine 1 levels were observed in rats with confirmed DVT compared to control and pre-thrombosis groups.
- Bioinformatic analysis revealed TGF-β1 as an upstream regulator of Serpine 1, capable of inducing its overexpression.
Conclusions:
- Overexpression of TGF-β1 and Serpine 1 is closely associated with the development of DVT in rats.
- These molecular changes may play a critical role in DVT formation.
- TGF-β1 and Serpine 1 hold potential as predictive biomarkers for DVT.
Related Concept Videos
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
438
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
438
01:30Venous Thrombosis I: Introduction
690
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
690
01:17Intracellular Signaling Affects Focal Adhesions
3.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.8K
01:29Venous Thrombosis III: Interprofessional Care
465
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
465
01:16Vascular Spasm
4.8K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.8K
01:16TGF - β Signaling Pathway
10.9K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K